Group One Trading’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2
Closed -$14 8949
2025
Q2
$19 Hold
2
﹤0.01% 7819
2025
Q1
$17 Hold
2
﹤0.01% 7443
2024
Q4
$27 Hold
2
﹤0.01% 7136
2024
Q3
$33 Hold
2
﹤0.01% 6509
2024
Q2
$37 Hold
2
﹤0.01% 6577
2024
Q1
$63 Hold
2
﹤0.01% 6857
2023
Q4
$47 Hold
2
﹤0.01% 7235
2023
Q3
$31 Hold
2
﹤0.01% 7514
2023
Q2
$44 Sell
2
-3
-60% -$59 ﹤0.01% 7543
2023
Q1
$96 Sell
5
-10
-67% -$271 ﹤0.01% 7036
2022
Q4
$414 Hold
15
﹤0.01% 6964
2022
Q3
$0 Hold
15
﹤0.01% 8053
2022
Q2
$1K Sell
15
-100
-87% -$4.67K ﹤0.01% 7601
2022
Q1
$7K Buy
+115
New +$9.48K ﹤0.01% 7306

Other funds holding PASG

Group One Trading's PASG Position: Q3 2025 in Review

Group One Trading sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 2 shares — an estimated $14 sold.

Group One Trading first reported a position in PASG in Q1 2022 and held it in 14 quarters. The position peaked at $7K in Q1 2022. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Group One Trading reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 2 Passage Bio shares in Q3 2025, an estimated $14.
  • Group One Trading first reported a position in Passage Bio in Q1 2022 and held it in 14 quarters.
  • Group One Trading's Passage Bio position peaked at $7K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.